{"entity":{"type":"insider","cik":"0002012715","url":"/insider/0002012715","json_url":"/insider/0002012715.json","name":"Nayak Sanjay","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":10,"first":"2024-05-28","last":"2026-05-28","span_basis":"filed_date"},"name_variants":[{"name":"Nayak Sanjay","source":"filing","n_filings":10,"first_seen":"2024-05-28","last_seen":"2026-05-28"}],"transactions":[{"id":6014986,"accession":"0001104659-26-067478","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-067478","line_url":"/filing/0001104659-26-067478#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002012715","owner_name":"Nayak Sanjay","owner_display_name":"Nayak Sanjay","owner_url":"/insider/0002012715","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1858.0,"shares_display":"1,858","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":15235.6,"total_display":"15,235.60","total_whole":"15,236","shares_owned_after":328795.0,"shares_owned_after_display":"328,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-26","filed_date":"2026-05-28","scope":"insider"},{"id":5942459,"accession":"0001104659-26-019802","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-019802","line_url":"/filing/0001104659-26-019802#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002012715","owner_name":"Nayak Sanjay","owner_display_name":"Nayak Sanjay","owner_url":"/insider/0002012715","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1759.0,"shares_display":"1,759","price_per_share":8.28,"price_display":"8.28","price_state":"stated","total_value":14564.52,"total_display":"14,564.52","total_whole":"14,565","shares_owned_after":330653.0,"shares_owned_after_display":"330,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-25","scope":"insider"},{"id":6056529,"accession":"0001104659-26-016667","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-016667","line_url":"/filing/0001104659-26-016667#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002012715","owner_name":"Nayak Sanjay","owner_display_name":"Nayak Sanjay","owner_url":"/insider/0002012715","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10348.0,"shares_display":"10,348","price_per_share":9.04,"price_display":"9.04","price_state":"stated","total_value":93545.92,"total_display":"93,545.92","total_whole":"93,546","shares_owned_after":332412.0,"shares_owned_after_display":"332,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-17","scope":"insider"},{"id":4510636,"accession":"0001104659-25-116425","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-116425","line_url":"/filing/0001104659-25-116425#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002012715","owner_name":"Nayak Sanjay","owner_display_name":"Nayak Sanjay","owner_url":"/insider/0002012715","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1878.0,"shares_display":"1,878","price_per_share":12.04,"price_display":"12.04","price_state":"stated","total_value":22611.12,"total_display":"22,611.12","total_whole":"22,611","shares_owned_after":277860.0,"shares_owned_after_display":"277,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-26","scope":"insider"},{"id":4510104,"accession":"0001104659-25-084116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-084116","line_url":"/filing/0001104659-25-084116#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002012715","owner_name":"Nayak Sanjay","owner_display_name":"Nayak Sanjay","owner_url":"/insider/0002012715","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1885.0,"shares_display":"1,885","price_per_share":12.04,"price_display":"12.04","price_state":"stated","total_value":22695.4,"total_display":"22,695.40","total_whole":"22,695","shares_owned_after":279738.0,"shares_owned_after_display":"279,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-27","scope":"insider"},{"id":4249297,"accession":"0001104659-25-053094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-053094","line_url":"/filing/0001104659-25-053094#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002012715","owner_name":"Nayak Sanjay","owner_display_name":"Nayak Sanjay","owner_url":"/insider/0002012715","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1862.0,"shares_display":"1,862","price_per_share":7.17,"price_display":"7.17","price_state":"stated","total_value":13350.54,"total_display":"13,350.54","total_whole":"13,351","shares_owned_after":281623.0,"shares_owned_after_display":"281,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-23","filed_date":"2025-05-27","scope":"insider"},{"id":4955367,"accession":"0001104659-25-017562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-017562","line_url":"/filing/0001104659-25-017562#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002012715","owner_name":"Nayak Sanjay","owner_display_name":"Nayak Sanjay","owner_url":"/insider/0002012715","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1895.0,"shares_display":"1,895","price_per_share":6.84,"price_display":"6.84","price_state":"stated","total_value":12961.8,"total_display":"12,961.80","total_whole":"12,962","shares_owned_after":283485.0,"shares_owned_after_display":"283,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-24","filed_date":"2025-02-26","scope":"insider"},{"id":3022959,"accession":"0001104659-24-123410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-123410","line_url":"/filing/0001104659-24-123410#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002012715","owner_name":"Nayak Sanjay","owner_display_name":"Nayak Sanjay","owner_url":"/insider/0002012715","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1814.0,"shares_display":"1,814","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":16326.0,"total_display":"16,326.00","total_whole":"16,326","shares_owned_after":174380.0,"shares_owned_after_display":"174,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-25","filed_date":"2024-11-27","scope":"insider"},{"id":2623473,"accession":"0001104659-24-093503","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-093503","line_url":"/filing/0001104659-24-093503#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002012715","owner_name":"Nayak Sanjay","owner_display_name":"Nayak Sanjay","owner_url":"/insider/0002012715","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1832.0,"shares_display":"1,832","price_per_share":9.02,"price_display":"9.02","price_state":"stated","total_value":16524.64,"total_display":"16,524.64","total_whole":"16,525","shares_owned_after":176194.0,"shares_owned_after_display":"176,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-27","scope":"insider"},{"id":2212992,"accession":"0001104659-24-065645","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-065645","line_url":"/filing/0001104659-24-065645#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002012715","owner_name":"Nayak Sanjay","owner_display_name":"Nayak Sanjay","owner_url":"/insider/0002012715","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2274.0,"shares_display":"2,274","price_per_share":5.84,"price_display":"5.84","price_state":"stated","total_value":13280.16,"total_display":"13,280.16","total_whole":"13,280","shares_owned_after":178026.0,"shares_owned_after_display":"178,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-23","filed_date":"2024-05-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001393434","name":"OCULAR THERAPEUTIX, INC","url":"/issuer/0001393434","role":"Officer (Chief Strategy Officer)","n_filings":10,"first_seen":"2024-05-28","last_seen":"2026-05-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002012715","retrieved_at":"2026-08-22T15:15:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}